top of page

Francois Potus

Francois Potus

Project Description:

Pulmonary arterial hypertension is a disease in which the blood vessels of the lungs become narrow and stiff. The right side of the heart must then work far harder to push blood through them, and over time it begins to fail. How well that right ventricle holds up is the single strongest predictor of how a patient will do.


Sotatercept is a new drug, recently approved, that has changed what is possible for people living with PAH. It works by rebalancing signals that drive the thickening of lung blood vessels. But something in the clinical trial data does not fit that explanation alone: patients improve within days, far faster than blood vessels can remodel. At the same time, measures of how well the heart pumps did not improve as expected.


Our project asks what else this drug is doing. We will test whether sotatercept relaxes lung blood vessels directly and immediately, which would explain the rapid improvement patients feel, and whether it acts on the heart muscle itself. To do this we use living slices of human lung and human heart tissue that continue to react and beat in the laboratory, alongside a rat model that isolates strain on the heart from disease in the lungs. Our group holds one of the largest collections of PAH lung and heart tissue in Canada.


Understanding the full picture will help doctors know which patients need closer monitoring, and guide the design of safer, more precisely targeted therapies.


Bio:

François Potus, PhD, is an Associate Professor in the Department of Medicine at Université Laval and a principal investigator in the Pulmonary Hypertension Research Group at the Quebec Heart and Lung Institute (IUCPQ) in Quebec City.


He completed his undergraduate and master’s training in France before moving to Quebec for his doctorate, which he finished at Université Laval in 2017. He then spent three years as a postdoctoral fellow at Queen’s University in Kingston before returning to Quebec City in 2020 to join the group.


His research asks why the right side of the heart fails in pulmonary arterial hypertension. He works translationally wherever possible, combining studies on human tissue with preclinical models. His work is funded by the Canadian Institutes of Health Research, and he holds a Junior 1 research scholarship from the Fonds de recherche du Québec – Santé.

PHA Canada

408 - 55 Water Street

Office 8928

Vancouver, BC, V6B 1A1

Email: info@phacanada.ca

Phone: 604-682-1036

Toll Free: 1-877-774-2226

Charitable Registration # 872050224RR0001

  • Instagram
  • Facebook
  • X
  • LinkedIn
  • Youtube

Copyright 2025 PHA CANADA, ALL RIGHTS RESERVED   |   Website created by Creativibe

bottom of page